Research programme: vaccines - Mariposa Health

Drug Profile

Research programme: vaccines - Mariposa Health

Alternative Names: Golden staph vaccine - Hunter Immunology; H 003; H 003 plus adjuvant; MH 003

Latest Information Update: 07 Jan 2016

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Hunter Immunology
  • Developer Mariposa Health Limited
  • Class
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Preclinical Staphylococcal infections
  • Discontinued Candidiasis; Pseudomonal infections

Most Recent Events

  • 07 Jan 2016 Discontinued - Preclinical for Candidiasis in Australia (PO)
  • 07 Jan 2016 Discontinued - Preclinical for Pseudomonal infections in Australia (PO)
  • 25 Jun 2015 Preclinical trials in Staphylococcal infections in Australia (PO)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top